AG002O30

23672-07-3 | N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide

Chemical structure of N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide, CAS 23672-07-3
AG002O30
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 23672-07-3
Catalog Number AG002O30(AGN-PC-0QZSWN)
Chemical Name N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide
IUPAC Name N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide
InChI InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)/t11-/m0/s1
InChI Key BGRJTUBHPOOWDU-NSHDSACASA-N
MDL Number MFCD00055220
Molecular Formula C15H23N3O4S
Molecular Weight 341.4258
SMILES NS(=O)(=O)C=1C=CC(=C(C(=O)NC[C@H]2N(CCC2)CC)C1)OC
UNII JTG7R315LK
Synonyms
levopraid, levosulpiride, N-(((S)-1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide, RV-12309, Levosulpiride, 23672-07-3, (-)-Sulpiride, (S)-(-)-sulpiride, Levopraid, S-(-)-Sulpiride, Levosulpirida, Levosulpiridum, (S)-sulpiride, UNII-JTG7R315LK, RV-12309, JTG7R315LK, Levobren, L-Sulpiride, CHEBI:64119, (S)-(-)-N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide, (S)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-methoxy-5-sulfamoylbenzamide, S-(-)-N-(1-Ethyl-2-pyrrolidinomethyl)-2-methoxy-5-sulfamoylebenzamide, MFCD00055220, NCGC00024853-05, (-)-N-(((S)-1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide, N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide, N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide, (S)-(-)-5-aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide, DSSTox_CID_22583, DSSTox_RID_80052, DSSTox_GSID_42583, Levopride, Nexipride, (S)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide, SMR000466366, CAS-23672-07-3, SULPIRIDE,(+), Levogastrol, Levosulpride, Sulpid, Sulpiride-l, S-Sulpiride, Sulpiride-S, (S)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide, N-[((2S)-1-ethylpyrrolidin-2-yl)methyl](6-methoxy-3-sulfamoylphenyl)carboxamid e, Benzamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoyl-, S-(-)-, Levopraid (TN), CAS-15676-16-1, Tocris-0895, levosulpiride-levogastrol, Sulpiride [L-(-)], AC1LELQ0, Biomol-NT_000030, Levosulpiride (Levogastrol), Lopac0_001089, SCHEMBL70112, GTPL958, MLS000759490, MLS001424014, BPBio1_001221, CHEMBL267044, DTXSID0042583, BDBM81774, CTK8B3281, ZINC57008, BGRJTUBHPOOWDU-NSHDSACASA-N, o-ANISAMIDE, N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-5-SULFAMOYL-, (S)-(-)-, HMS2051A08, HMS2089E04, HMS2232P10, HMS3263I20, HMS3266P14, HMS3675D20, HY-B1059, Tox21_110933, Tox21_501089, ANW-42196, BG0325, CL-004, GP2472, PDSP1_000516, PDSP1_000620, PDSP1_001649, PDSP2_000514, PDSP2_000616, s2104, SBB058180, AKOS007930553, AKOS015897363, Tox21_110933_1, AC-6821, API0003164, BCP9000853, CCG-100847, CS-4581, KS-5103, LP01089, NC00097, NCGC00015966-10, NCGC00016718-01, NCGC00024853-01, NCGC00024853-02, NCGC00024853-03, NCGC00024853-04, NCGC00024853-06, NCGC00024853-09, NCGC00261774-01, CC-29928, CPD000466366, SAM001246703, SC-76846, BCP0726000072, AB1009626, CAS_15676-16-1, TL8001954, (S)-(-)-Sulpiride, >=98% (titration), EU-0101089, I0821, ST50319539, SW197477-2, D07312, K-6442, S 7771, AB00639965-06, AB00639965-08, AB00639965_09, 672L073, C-20361, SR-01000076136, SR-01000597436, J-015181, SR-01000076136-2, SR-01000597436-1, BRD-K51671335-001-01-5, BRD-K51671335-001-04-9, (S)-(-)-Sulpiride, VETRANAL(TM), analytical standard, UNII-7MNE9M8287 component BGRJTUBHPOOWDU-NSHDSACASA-N, (-)-N-[(1-Ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-o-anisamide, (-)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide, 5-(Aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-benzamide, 5-(Aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxy-benzamide, Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-, (S)- (9CI), 5-HT6 Serotonin Receptor from rat, recombinant, expressed in HEK 293 cells, membrane suspension, sulpiride, lesuride, null, Levosulpiride?, Levosulpiride [INN], Levosulpiride (INN), Levosulpiridum [INN-Latin], Levosulpirida [INN-Spanish], (RS)-(+/-)-sulpiride, ACN-S005456, C15-H23-N3-O4-S, CID688272, CS-O-01769, B1484, C078143, N-(((S)-1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide, (S)-(-)-Sulpiride, 98%, a selective antagonist for D2 dopamine receptor - 25G 25g, Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-, (S)-, 15676-16-1,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited